Costly GLP-1 drug use for weight loss has soared, study reports
Educatie
The number of Americans taking cutting-edge weight-loss drugs like Ozempic , Wegovy and Zepbound has skyrocketed in recent years, a new study says. The number of people without diabetes taking a GLP-1 drug more than tripled between 2018 and 2022 in the United States, researchers reported Monday in the Annals of Internal Medicine . Advertisement Spending on these drugs reached $5.8 billion in 2022, with average prices consistently exceeding $1,500 per prescription, results show. "Despite this,
din zilele anterioare